BRIEF published on 06/12/2025 at 11:05, 11 months 20 days ago Relief Therapeutics Announces Results of Annual General Meeting Financial Statements Shareholder Approval Annual Meeting Board Elections Compensation Approval
PRESS RELEASE published on 06/12/2025 at 11:00, 11 months 20 days ago Relief Therapeutics Announces Results of Annual General Meeting Relief Therapeutics announces results of its Annual General Meeting with shareholders approving all proposals by a large majority. AGM covers key agenda items and re-election of board members and auditors Board Of Directors Annual General Meeting Shareholders Relief Therapeutics AGM Results
BRIEF published on 05/22/2025 at 07:05, 1 year ago Relief Therapeutics Secures FDA Rare Pediatric Disease Designation for RLF-TD011 FDA Relief Therapeutics RLF-TD011 Epidermolysis Bullosa Rare Pediatric Disease
PRESS RELEASE published on 05/22/2025 at 07:00, 1 year ago Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011 Relief Therapeutics granted FDA Rare Pediatric Disease Designation for RLF-TD011 in treating epidermolysis bullosa, a rare genetic skin disorder. Potent antimicrobial & anti-inflammatory activity shown FDA Relief Therapeutics RLF-TD011 Epidermolysis Bullosa Rare Pediatric Disease Designation
BRIEF published on 05/15/2025 at 07:05, 1 year ago Relief Therapeutics Announces 2025 AGM Agenda Annual General Meeting Financial Statements Shareholder Voting Board Re-election Compensation Approval
PRESS RELEASE published on 05/15/2025 at 07:00, 1 year ago Relief Therapeutics Publishes 2025 Annual General Meeting Agenda Relief Therapeutics announces agenda for its 2025 Annual General Meeting featuring key resolutions and re-elections. Meeting scheduled for June 12 in Geneva, Switzerland Shareholders Switzerland Relief Therapeutics Agenda 2025 Annual General Meeting
BRIEF published on 04/10/2025 at 07:05, 1 year 1 month ago Relief Therapeutics Announces 2024 Financial Results and Strategic Progress Biopharmaceutical Relief Therapeutics Rare Diseases 2024 Financial Results Pipeline Progress
PRESS RELEASE published on 04/10/2025 at 07:00, 1 year 1 month ago Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update Relief Therapeutics reports 2024 financial results and provides a corporate update, emphasizing operational achievements, pipeline momentum, and strengthened financial position Biopharmaceutical Corporate Update Relief Therapeutics Rare Diseases 2024 Financial Results
BRIEF published on 03/06/2025 at 07:05, 1 year 2 months ago Relief Therapeutics Ends Merger Discussions with Renexxion Shareholder Value Relief Therapeutics Strategic Objectives Renexxion Merger Termination
PRESS RELEASE published on 03/06/2025 at 07:00, 1 year 2 months ago Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion Relief Therapeutics terminates merger discussions with Renexxion after failing to meet key conditions. Company remains well-positioned with robust pipeline and cash reserves Relief Therapeutics Cash Reserves Therapeutic Pipeline Renexxion Merger Discussions
Published on 06/02/2026 at 13:00, 31 minutes ago Uraniumx Reports Visually Identified Pitchblende At Murphy Lake
Published on 06/02/2026 at 13:00, 31 minutes ago AI/ML Subsidiary NeuralCloud Appoints Cardiac Monitoring Veterans Dale and Nicholas DuBois to Lead Clinical and Overread Operations
Published on 06/02/2026 at 11:00, 2 hours 31 minutes ago Snipp Interactive Reports Q1 2026 Financial Results; Bookings Backlog Reaches Record $20.6 Million; Announces Conference Call on Wednesday, June 3, 2026Vancouver, BC, Canada - June 2, 2026
Published on 06/02/2026 at 11:00, 2 hours 31 minutes ago American Critical Minerals to Attend Benchmark Mineral Intelligence's GIGA USA 2026 Conference as Company focuses on US Govt. Initiatives
Published on 06/02/2026 at 09:01, 4 hours 30 minutes ago Star Copper Begins Drilling at Star East Target as 15,000 Metre 2026 Exploration Campaign Gets Underway
Published on 06/02/2026 at 13:05, 26 minutes ago MMDSmart Accelerates Global Growth, Doubling Its Workforce with Double Digit CAGR
Published on 06/02/2026 at 12:50, 41 minutes ago Benefiting SMBs and OPCs: MINISFORUM Unveils Private AI Agent NAS Ecosystems at COMPUTEX 2026
Published on 06/02/2026 at 12:30, 1 hour 1 minute ago Infosys Expands Strategic Collaboration with DNB Bank ASA to Modernize Financial Crime Operations
Published on 06/02/2026 at 08:00, 5 hours 31 minutes ago EURAZEO’S PRIVATE DEBT FUND CLOSES AT RECORD €3.9 BILLION, EXCEEDING ITS INITIAL TARGET
Published on 06/02/2026 at 07:30, 6 hours 1 minute ago OPmobility strengthens its U.S. footprint with a new state-of-the-art plant in the Midwest
Published on 06/02/2026 at 07:00, 6 hours 31 minutes ago BIOPHYTIS STRATEGIC UPDATE: JOINT VENTURE REGISTRATION FILING SUBMITTED IN HONG KONG
Published on 06/01/2026 at 18:47, 18 hours 44 minutes ago Disclosure of transactions in own shares from May 25 to May 29, 2026
Published on 06/01/2026 at 18:00, 19 hours 31 minutes ago Covivio - Information on total number of voting rights and share capital
